Evelo Biosciences Inc (OTCPK:EVLO)
$ 0.06 0 (0%) Market Cap: 1.14 Mil Enterprise Value: 17.82 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 0/100

Evelo Biosciences Inc at Morgan Stanley 18th Annual Global Healthcare Conference (Virtual) Transcript

Sep 14, 2020 / 08:30PM GMT
Release Date Price: $103.6 (+10.45%)
Matthew Kelsey Harrison
Morgan Stanley, Research Division - Executive Director

Good afternoon, everybody. Thanks for joining us for the next session. I'm Matthew Harrison, one of the biotech analysts here at Morgan Stanley. Pleased to have Evelo with me for the next session.

Briefly, before we get started, I need to read a disclosure statement. Please note that this webcast is for Morgan Stanley's clients and appropriate Morgan Stanley employees only. This webcast is not for members of the press. If you are a member of the press, please disconnect and reach out separately.

For important disclosures, please see the Morgan Stanley research disclosure website at morganstanley.com/researchdisclosures. If you have any questions, please reach out to your Morgan Stanley representative.

So with that, very pleased to have Simba Gill, who is the CEO of Evelo, join us.

Questions & Answers

Matthew Kelsey Harrison
Morgan Stanley, Research Division - Executive Director

And Simba, I thought that maybe a good place to start would be

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot